| Literature DB >> 34193256 |
Xingcui Zhang1,2,3, Yanting Zhang1,2,3, Renyong Jia4,5,6, Mingshu Wang1,2,3, Zhongqiong Yin3, Anchun Cheng7,8,9.
Abstract
Flaviviruses are enveloped single positive-stranded RNA viruses. The capsid (C), a structural protein of flavivirus, is dimeric and alpha-helical, with several special structural and functional features. The functions of the C protein go far beyond a structural role in virions. It is not only responsible for encapsidation to protect the viral RNA but also able to interact with various host proteins to promote virus proliferation. Therefore, the C protein plays an important role in infected host cells and the viral life cycle. Flaviviruses have been shown to affect the health of humans and animals. Thus, there is an urgent need to effectively control flavivirus infections. The structure of the flavivirus virion has been determined, but there is relatively little information about the function of the C protein. Hence, a greater understanding of the role of the C protein in viral infections will help to discover novel antiviral strategies and provide a promising starting point for the further development of flavivirus vaccines or therapeutics.Entities:
Keywords: Flavivirus; capsid protein; ecapsidation; therapeutic; vaccine
Year: 2021 PMID: 34193256 PMCID: PMC8247181 DOI: 10.1186/s13567-021-00966-2
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Figure 1Propagation process of flaviviruses. Flavivirus propagation mainly includes adsorption, entrance, replication, assembly, maturity and release. The virus enters host cells through host receptor recognition (A); then, the virus fuses with the host membrane (B), and the RNA of flavivirus is ejected from the nucleocapsid and released into the cytoplasm of the host cells (C). RNA replication, protein synthesis and particle assembly are carried out in the ER (D and E); the particles mature in the Golgi apparatus (F); subsequently, mature virions are released from the host cells (G).
Figure 23D structure of the flavivirus capsid protein. Topological diagram of a C protein homodimer: α-helices 1–4 of each C monomer are shown in light blue, green, purple and dark blue, respectively. The α1–α1′ and α2–α2′ helices are located on the opposite side of the α4–α4′ helices, and the α3–α3′ helix is parallel to the α4–α4′ helix. The 3D structure was created with PyMOL software.
Figure 3Infectious particle of the flavivirus. The viral RNA genome is packaged in a spherical nucleocapsid composed of multiple copies of the C protein. The structural proteins prM/E and lipid bilayer enclose the nucleocapsid core.
Figure 4Multiple functions of the C protein. The C protein is a flavivirus structural protein that has both structural and nonstructural functions. Vaccines and antiviral drugs can exploit various functional characteristics of the C protein.
Applications of flavivirus capsid proteins
| Proteins | Viruses | Virus strains | Application types | References |
|---|---|---|---|---|
| EDIII and C | DENV | Hawaii (DENV-1) New Guinea C (DENV-2) H-87 (DENV-3) H241 (DENV-4) DENV-2 A15 DENV-2 SB8553/S16803 | Subunit vaccine | [ |
DENV-1 Jamaica (AF42564) DENV-2 SB8553 DENV-3 (FJ882576) DENV-4 (AF326573) | Vaccine | [ | ||
DENV-2 A-15 strain DENV-2 SB8553 DENV-2 Jamaica | Vaccine | [ | ||
| C | Hawaii (DENV-1) New Guinea C (DENV-2) H-87 (DENV-3) H241 (DENV-4) DENV-2 SB8553 | Vaccine | [ | |
| Four serotypes | Antiviral agent | [ | ||
| C | JEV | Wild-type and 9798A mutant of JEV AT31 | Antiviral agent | [ |
| Wild-type and L17A/CSmt JEVs | Pathogenesis of JEV infection | [ | ||
| C | WNV | WNV NY99 | Live vaccine candidates | [ |
| C | TMUV | DTMUV WR strain | DNA vaccine | [ |
| CQW1 strain | Target therapeutic | [ | ||
| C-prM-E | ZIKV | PRVABC59 | Virus-like particle vaccines | [ |
| C | FSS13025 strain | Live-attenuated vaccine | [ | |
| VSV-C | PRVABC59 strain | Vesicular stomatitis virus (VSV)-based vaccine | [ |